Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
16.48 USD | +6.56% | -14.84% | +9.00% |
06-18 | Exchange-Traded Funds, Equity Futures Mixed Pre-Bell Ahead of Speeches by Fed Officials | MT |
06-14 | Oppenheimer Adjusts UroGen Pharma Price Target to $40 From $32, Maintains Outperform Rating | MT |
- Stock Market
- Equities
- URGN Stock
- News UroGen Pharma Ltd.
- MarketScreener Editorial Features